Privi Speciality Chemicals Ltd (NSE:PRIVISCL)

Q4 2026 Privi Speciality Chemicals Ltd Earnings Call Transcript

May 12, 2026 / 10:30 AM GMT

Release Date Price: ₹3198.7 (-7.90%)

Transcript

Key Points

Positve

Privi Speciality Chemicals Ltd (BOM:530117) reported a strong financial performance for FY 25-26, with a 22% revenue growth year-on-year.
The company achieved a consistent EBITDA margin of over 25% throughout the year, indicating strong operational efficiency.
The joint venture with Prijiv turned profitable in Q4, contributing positively to the company's financials.
Privi is on track with its CapEx expansion, expected to increase installed capacity to 54,000 metric tonnes per annum by June 2026.
The company has a robust product pipeline with 75 products and 15 more in development, enhancing its market position and customer satisfaction.

Negative

There was a significant dip in gross margins sequentially, attributed to the overlap of raw material contracts.
The company's working capital cycle stands at 117 days, with potential for a slight increase due to current market conditions.
Despite strong financials, the company faces challenges in maintaining its margins amidst volatile raw material and energy costs.
The biotechnology and renewable feedstock projects are still in the demonstration phase, with commercial viability yet to be proven.
The merger process with Privy Fine Sciences and Privy Biotechnologies is ongoing, with final approval expected in FY 2026-27, which may delay potential synergies.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PIVI.NS - Privi Speciality Chemicals Ltd
Q4 2026 Privi Speciality Chemicals Ltd Earnings Call
May 12, 2026 / 10:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and Gentlemen, good day and welcome to the PV Specialty Chemicals Limited's Q4 and FY 2026 Earnings Conference Call.

As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during the conference call, please signal an operator by pressing and 0 on your touchstone 4.

From the management we have with us.

Mr. Mahesh Pabani, Chairman and Managing Director, Mr. R. S. Rajan, President, Mr. Sanjeev Patil, Executive Vice President, Strategy and Biotechnology, Miss Narayan Nair, Chief Financial Officer, Miss Ashwini Shah, Company Secretary and

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.